These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7587604)

  • 1. [The effectiveness of combined insulin and sulfonylurea in treating non-insulin dependent diabetic patients].
    Sun Y; Xiong Y; Yang J
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):246-9. PubMed ID: 7587604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.
    Allen BT; Feinglos MN; Lebovitz HE
    Arch Intern Med; 1985 Oct; 145(10):1900-3. PubMed ID: 3899039
    [No Abstract]   [Full Text] [Related]  

  • 4. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine.
    Riddle MC
    Horm Metab Res; 1996 Sep; 28(9):430-3. PubMed ID: 8911978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
    Kabadi MU; Kabadi UM
    Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and tolerance of long-term acarbose therapy in diabetic patients with threatened secondary failure of sulfonylurea drug treatment].
    Domke A; Willms B
    Med Klin (Munich); 1994 Apr; 89(4):187-92. PubMed ID: 8015532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy with sulfonylurea plus insulin in "secondary failure" of type 2 diabetes].
    Lotz N
    Ther Umsch; 1990 Jan; 47(1):49-54. PubMed ID: 2408182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination treatment with insulin and sulfonylurea. Results of a 5-year study].
    Holländer E
    Z Gesamte Inn Med; 1989 May; 44(9):261-4. PubMed ID: 2662659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delayed sulfonylurea resistance in non-insulin-dependent diabetes mellitus].
    Farkas K; Jermendy G; Somogyi A
    Orv Hetil; 1997 Nov; 138(48):3031-5. PubMed ID: 9441264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
    Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY
    Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin resistance and combined therapy with sulfonylurea and insulin in non-insulin dependent diabetics].
    Vozár J
    Vnitr Lek; 1995 Feb; 41(2):141-5. PubMed ID: 7725640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V; Snehalatha C; Ramachandran A; Viswanathan M
    J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual effects of a short-term intensified insulin therapy in type 2 diabetic patients with oral drug failure.
    Féry F; Desir D; Mockel J
    Diabete Metab; 1991; 17(6):525-9. PubMed ID: 1809598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The importance of concurrent therapy with insulin and sulfonylurea derivatives in type II diabetes].
    Podrouzková B
    Vnitr Lek; 1994 May; 40(5):310-2. PubMed ID: 8023473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic management of the secondary failure of sulfonylurea therapy].
    Sauer H
    Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.